Biomedicine & Advanced Nuclear Medicine (BNCT Tumor Therapy)

July 31, 2026

Biomedicine & Advanced Nuclear Medicine (BNCT Tumor Therapy)

Target Clients: Nuclear drug R&D enterprises, BNCT centers in oncology hospitals, biomedical research institutes

Enriched Boric Acid-10

Application: Synthesizes boron-targeted delivery agents for BNCT tumor therapy (e.g., BPA, BSH), functioning as the key upstream precursor raw material for boron neutron capture therapy pharmaceuticals.

Isotope-Enriched Boron-10 (Customizable Elemental/Compound Forms)

Application: Core boron source for clinical BNCT agents. It accumulates selectively within tumor cells and, upon bombardment by external neutron beams, precisely destroys cancerous cells.

leave a message
leave a message
Interested in our boron materials? Please leave a message with your requirements — our technical sales team will respond within 24 hours.
leave a message
Interested in our boron materials? Please leave a message with your requirements — our technical sales team will respond within 24 hours.

home

products

WhatsApp

Contact Us